BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 21489644)

  • 1. India's growing participation in global clinical trials.
    Gupta YK; Padhy BM
    Trends Pharmacol Sci; 2011 Jun; 32(6):327-9. PubMed ID: 21489644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials in India.
    Maiti R; M R
    Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. India's drug tests.
    Padma TV
    Nature; 2005 Jul; 436(7050):485. PubMed ID: 16049471
    [No Abstract]   [Full Text] [Related]  

  • 4. India's growing clinical research sector: opportunity for global companies.
    Varawalla N
    IDrugs; 2007 Jun; 10(6):391-4. PubMed ID: 17642002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The perverse consequences of a proposed global tax on research.
    MacDonald C; Walton N
    Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
    [No Abstract]   [Full Text] [Related]  

  • 7. Outsourcing clinical trials.
    Hanauer SB
    Nat Rev Gastroenterol Hepatol; 2009 Apr; 6(4):191. PubMed ID: 19347005
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical futures: made in China?
    Cyranoski D
    Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
    [No Abstract]   [Full Text] [Related]  

  • 9. Fast, cheap, and out of control? Speculations and ethical concerns in the conduct of outsourced clinical trials in India.
    Kamat VR
    Soc Sci Med; 2014 Mar; 104():48-55. PubMed ID: 24581061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Justice in the application of science: beyond fair benefits.
    London AJ
    Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
    [No Abstract]   [Full Text] [Related]  

  • 11. A new colonialism?--Conducting clinical trials in India.
    Nundy S; Gulhati CM
    N Engl J Med; 2005 Apr; 352(16):1633-6. PubMed ID: 15843665
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonconsensual clinical trials: a foreseeable risk of offshoring under global corporatism.
    Spielman B
    J Bioeth Inq; 2015 Mar; 12(1):101-6. PubMed ID: 25630592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to open peer commentaries on "How to do research fairly in an unjust world".
    Ballantyne AJ
    Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959
    [No Abstract]   [Full Text] [Related]  

  • 14. Trading on traditional medicines.
    Basu P
    Nat Biotechnol; 2004 Mar; 22(3):263-5. PubMed ID: 14990941
    [No Abstract]   [Full Text] [Related]  

  • 15. For-profit clinical trials in developing countries--those troublesome patient benefits.
    Schuklenk U
    Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 17. How to do research fairly in an unjust world.
    Ballantyne AJ
    Am J Bioeth; 2010 Jun; 10(6):26-35. PubMed ID: 20526966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomanufacturing, from bust to boom...to bubble?
    Thiel KA
    Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
    [No Abstract]   [Full Text] [Related]  

  • 19. The quiet revolution: outsourcing in pharma.
    Crossley R
    Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
    [No Abstract]   [Full Text] [Related]  

  • 20. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.